Grupo de Trabajo Riesgo Vascular

Publicaciones

Publicaciones GT Riesgo Vascular 2023

Goya M, Miserachs M, Suy Franch A, Burgos J, de la Calle M, Brotons C, Castellanos M, Cortés Rico O, Díaz Rodriguez Á, Elosúa R, Freijo MDM, González Fondado M, Gorostidi M, Grau M, Hernández Martínez AM, Lahoz C, Muñoz-Rivas N, Pallares-Carratalá V, Pedro-Botet J, Rodilla E, Goya E, Royo Bordonada MÁ, Santamaría R, Torres Fonseca M, Velescu A, Zamora A, Armario P. [Documento de consenso de la Sociedad Española de Obstetricia y Ginecologia (SEGO) y el Comité Español Interdisciplinario para la Prevención Vascular (CEIPV).

Leer más sobre Publicaciones GT Riesgo Vascular 2023

Publicaciones GT Riesgo Vascular 2021

Castilla-Guerra L, Gómez Escobar A, Gómez Cerezo JF. Utility of Doppler ultrasound for the study of ocular vascular disease.Rev Clin Esp (Barc). 2021 Aug-Sep;221(7):418-425. doi: 10.1016/j.rceng.2020.11.007. Epub 2021 May 29.
Mostaza JM, Suarez C, Cepeda JM, Manzano L, Sánchez D; PERFILAR study investigators. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation. BMC Cardiovasc Disord. 2021 Aug 9;21(1):384. doi: 10.1186/s12872-021-02019-0. PMID: 34372782; PMCID: PMC8351138.

Leer más sobre Publicaciones GT Riesgo Vascular 2021

Publicaciones GT Riesgo Vascular 2020

Rodríguez-Pardo J, Fuentes B, Alonso de Leciñana M, Campollo J, Calleja Castaño P, Carneado Ruiz J, Egido Herrero J, García Leal R, Gil Núñez A, Gómez Cerezo JF, Martín Martínez A, Masjuán Vallejo J, Palomino Aguado B, Riera López N, Simón de Las Heras R, Vivancos Mora J, Díez Tejedor E; en nombre del Grupo Multidisciplinar del Plan Ictus Madrid.. Acute stroke care during the COVID-19 pandemic. Ictus Madrid Program recommendations. Neurologia. 2020 May;35(4):258-263. doi: 10.1016/j.nrl.2020.04.008. Epub 2020 Apr 24. English, Spanish.

Leer más sobre Publicaciones GT Riesgo Vascular 2020

Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19

It is unclear to which extent the higher mortality associated with hypertension in the coronavirus disease (COVID-19) is due to its increased prevalence among older patients or to specific mechanisms. Cross-sectional, observational, retrospective multicenter study, analyzing 12226 patients who required hospital admission in 150 Spanish centers included in the nationwide SEMI-COVID-19 Network. We compared the clinical characteristics of survivors versus non-survivors. The mean age of the study population was 67.5 ± 16.1 years, 42.6% were women. Overall, 2630 (21.5%) subjects died.